Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Yes. We need to remember that ultimate objective

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154275
(Total Views: 470)
Posted On: 04/02/2020 8:39:22 AM
Avatar
Posted By: TechGuru
Re: misiu143 #24765
Yes. We need to remember that ultimate objective is to help the patients survive:

Quote:
Patients enrolled in this trial are expected to be administered leronlimab for two weeks with the primary endpoint being the mortality rate at 14 days.



If the improvement in cytokines, IL-6, and a trend toward the normalization of the CD4/CD8 ratio results in improved survival rates we are contributing (and will be approved as a result).

When the time comes, the real question is: how are the patients doing so far?. Out of ventilators mean they very likely made it, still in ventilators and improving that they will likely make it. Not improving after few days that we could not help them and the odds are negative.

From CDY press release:

Quote:
Recent data from China indicates mortality rate among COVID-19 patients requiring mechanical ventilator is more than 85%



So, re-stating the question: will the significant improvement in several important immunologic bio-markers announced today result in 8 patients surviving (not clear about the other 2)?? This is only 3 days data so nobody knows that answer yet. For what we know most of them are still in ventilators hopefully improving:

Quote:
The current data suggests a trend toward the restoration of immune function and mitigation of the cytokine storm.



A PR from Nader will give us lots of "color" regarding what is happening ( maybe more than one are out of respirators already) but, with trials on going as we speak he might be a bit reluctant to provide details before outcomes are achieved.



(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us